Cambridge Cognition Holdings PLC
LSE:COG

Watchlist Manager
Cambridge Cognition Holdings PLC Logo
Cambridge Cognition Holdings PLC
LSE:COG
Watchlist
Price: 28 GBX 1.82%
Market Cap: 11.7m GBX
Have any thoughts about
Cambridge Cognition Holdings PLC?
Write Note

Cambridge Cognition Holdings PLC
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cambridge Cognition Holdings PLC
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Cambridge Cognition Holdings PLC
LSE:COG
Gross Profit
ÂŁ10.6m
CAGR 3-Years
17%
CAGR 5-Years
18%
CAGR 10-Years
10%
Renalytix PLC
LSE:RENX
Gross Profit
$701k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Craneware PLC
LSE:CRW
Gross Profit
$162.2m
CAGR 3-Years
32%
CAGR 5-Years
19%
CAGR 10-Years
15%
Intelligent Ultrasound Group PLC
LSE:IUG
Gross Profit
ÂŁ6m
CAGR 3-Years
23%
CAGR 5-Years
16%
CAGR 10-Years
N/A
EMIS Group PLC
LSE:EMIS
Gross Profit
ÂŁ165.9m
CAGR 3-Years
6%
CAGR 5-Years
3%
CAGR 10-Years
7%
Doctor Care Anywhere Group PLC
ASX:DOC
Gross Profit
ÂŁ10.8m
CAGR 3-Years
61%
CAGR 5-Years
72%
CAGR 10-Years
N/A
No Stocks Found

Cambridge Cognition Holdings PLC
Glance View

Market Cap
11.7m GBX
Industry
Health Care

Cambridge Cognition Holdings Plc is a neuroscience digital health company, which engages in the development of digital health products to better understand, detect, and treat conditions affecting brain health. The firm develops and markets digital solutions to assess brain health for sale worldwide, principally in the United Kingdom, the United States and Europe. Its products include CANTAB Recruit, CANTAB Connect, Cognition Kit, Cognition eCOA, CANTAB Connect Research, CANTAB Mobile, CANTAB BrainHealth, CANTAB Insight and NeuroVocalix. Its services include neuroscience consultancy, study design, data analysis, study management, data management plan, reporting and interpretation and technical consultancy. Its CANTAB Connect offers digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas. Its Cognition Kit is a custom-designed digital health platform delivering wearable and smartphone applications for high frequency data collection to demonstrate treatment efficacy and increase the understanding of a disease and a patient's response to medication.

COG Intrinsic Value
104.23 GBX
Undervaluation 73%
Intrinsic Value
Price

See Also

What is Cambridge Cognition Holdings PLC's Gross Profit?
Gross Profit
10.6m GBP

Based on the financial report for Jun 30, 2024, Cambridge Cognition Holdings PLC's Gross Profit amounts to 10.6m GBP.

What is Cambridge Cognition Holdings PLC's Gross Profit growth rate?
Gross Profit CAGR 10Y
10%

Over the last year, the Gross Profit growth was 12%. The average annual Gross Profit growth rates for Cambridge Cognition Holdings PLC have been 17% over the past three years , 18% over the past five years , and 10% over the past ten years .

Back to Top